U.S. FDA advises manufacturers to add a spike protein component of the Omicron subvariants BA.4 and BA.5 to their prototype vaccines for fall boosters.
The National Association of Pharmacy Regulatory Authorities (NAPRA) has published a new document the lays out the principles of professionalism for pharmacy.